5 selected, the lowest 7.9 yuan!

Shandong carries out special centralized procurement of antigen new coronavirus antigen detection reagent products, and the declared price is not higher than 1.
3 times of the lowest price or the decline is not less than 50%.
Five companies from Oriental Gene Biological Products and Tianjin Boaosaisi were selected
.

The average decline was 74.
7%, and the lowest price was only 7.
9 yuan per person (Shenzhen Huada Yinyuan), and a single company could earn up to 72 million yuan a day
.

According to the previous regulations, the companies that were not selected in this centralized procurement are not included in the scope of online procurement

On March 16, the Shandong Provincial Public Resource Trading Center announced the results of the special centralized procurement of new coronavirus antigen detection reagents for the Lujin Alliance.
11 companies applied to participate.
In the end, Shenzhen Huada Yinyuan, Beijing Wantai Biology, and Wuhan Mingde Biology , Zhejiang Dongfang Gene Biological Products, and Tianjin Boosaisi were selected, while Guangzhou Wanfu Biological, which had previously reduced prices in many provinces, did not win the bid
.

Judging from the announced selected price, the average market price of the new crown antigen detection kit has dropped from more than 30 yuan to less than 9 yuan, an average drop of 74.
7%
.

Among them, Shenzhen Huada Yinyuan has the lowest price, which is only 7.

Although the decline of each company is not small this time, the company will still not lose money
.

According to reports, the unit price of the new crown antigen detection reagent predicted by the agency is even as low as 2 yuan: GF Securities data shows that the current domestic production cost of one antigen self-test reagent is generally around 2 to 3 yuan; Huaan Securities predicts that antigen detection products The final retail price should be around 4 yuan

In addition, it has to be said that the response speed of this centralized procurement in Shandong Province was extremely fast, which refreshed the previous centralized procurement records, and completed the whole process from the issuance of the centralized procurement notice to the announcement of the selection results in less than two days
.

According to the relevant person in charge of the Shandong Provincial Medical Security Bureau, the next step will be to start the online work of the selected products immediately, and guide medical institutions and pharmaceutical companies to carry out online transactions
.

At the same time, urge the selected enterprises to deploy the supply as soon as possible, and strive to supply the goods in the shortest time

Several provinces have successively carried out relevant plans for the collection of novel coronavirus antigen detection reagents and the work of hanging on the Internet

Several provinces have successively carried out relevant plans for the collection of novel coronavirus antigen detection reagents and the work of hanging on the Internet

In April 2021, Guangdong Provincial Drug Trading Center launched the regional centralized procurement of new coronavirus detection reagents, and Wanfu Bio won the bid with a price of 16.
8 yuan per person
.

However, on March 15, 2022, Guangdong and Henan issued notices one after another, Guangzhou Wanfu Biological took the initiative to apply for the selection of the new coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) (National Machinery Note 20203400830) price Adjusted to 9.
8 yuan/person, a drop of 41.
67%

On March 14, 2022, Tianjin Pharmaceutical Purchasing Center announced to carry out centralized maintenance of novel coronavirus antigen detection reagent information
.

According to industry insiders, according to the usual practice, the maintenance of medicines and medical consumables (products) and enterprise information is the premise for enterprises to participate in bidding, procurement, and online listing, and is to strengthen the standardization of pharmaceutical product data and accelerate the formation of a national unified medical security information business code.

On March 16, the Inner Mongolia Autonomous Region Pharmaceutical Purchasing Center announced the launch of a centralized network of novel coronavirus antigen detection reagents to further optimize the novel coronavirus detection strategy and serve the needs of epidemic prevention and control